Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Torrent Pharmaceuticals Ltd. Share Price
Day's Range
Day's Range
Low
₹4,380.30
High
₹4,450.40
Price Summary
| Previous Close | ₹4,405.70 |
|---|---|
| Day's Range | ₹4,380.30 - ₹4,450.40 |
| Open | ₹4,425.00 |
| 52 Week Range | ₹3,102.00 - ₹4,555.10 |
| Volume | 3,03,882 |
| Market Cap | ₹0.15 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 13,403.83 |
|---|---|
| Market Cap (₹ in Mn) | 0.15 |
| Dividend Yield(%) | 0.73 |
| Price/Earning (TTM) | 65.64 |
| TTM EPS (₹) | 67.13 |
| P/E Ratio | 57.28 |
| Book Value(₹) | 16.42 |
| PAT Margin (%) | 11.34 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 27.32 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 23770.0 | 107280.0 |
| Expenses | N/A | N/A |
| PBT | 6510.0 | 23520.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 4850.0 | 16560.0 |
About Torrent Pharmaceuticals Ltd.
| Founded | 1972 |
|---|---|
| Managing Director | Aman Mehta |
| NSE Symbol | TORNTPHARM |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,51,074.97 | 1,879.90 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,79,485.96 | 6,755.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,124.14 | 4,386.00 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,16,201.01 | 8,077.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,640.69 | 1,431.55 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,11,589.46 | 1,336.95 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,03,966.32 | 2,273.90 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,03,368.09 | 2,507.00 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,02,190.60 | 1,050.05 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 1,01,755.41 | 1,011.25 | 835.50 - 835.50 |
No Records Found
Latest News
Krishna Institute of Medical Sciences informs about investor presentation
Onesource Specialty Pharma informs about updates
Acutaas Chemicals informs about corporate presentation
Apollo Hospitals Enterprise informs about conference call
Pursuant to Regulation 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Apollo Hospitals Enterprise has informed that a conference call for the analysts/investors is scheduled to be held on Thursday, 21st May 2026 at 3.00 pm to discuss the audited financial results of the Company for the quarter and year ended 31st March 2026.
The above information is a part of company’s filings submitted to BSE.
Krishna Institute of Medical Sciences informs about newspaper publication
Pursuant to the provisions of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has informed that it enclosed a copy of the newspaper publication on the audited (Standalone and Consolidated) financial results of the company for the quarter and financial year ended 31st March 2026, published in Financial Express (English) and Navatelangana (Telugu). The said publication may also be accessed on the website of the company.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Torrent Pharmaceuticals Ltd. is ₹4,405.70 as of 2026-05-15.
The market capitalisation of Torrent Pharmaceuticals Ltd. is ₹149,124.14 as of 2026-05-15.
The 1-year return of Torrent Pharmaceuticals Ltd. is 0.00% as of 2026-05-15.
The P/E ratio of Torrent Pharmaceuticals Ltd. is 57.28 as of 2026-05-17.
The 52-week high and low of Torrent Pharmaceuticals Ltd. are ₹4,555.10 and ₹3,102.00, respectively, as of 2026-05-15.
People Also Ask
Torrent Pharmaceuticals Ltd. manufactures a wide range of specialised branded generic medications. The company holds market presence in therapeutic segments such as cardiovascular, central nervous system, gastrointestinal, and women's healthcare products across India and global markets.
Torrent Pharmaceuticals Ltd. engages in partnerships by acquiring strategic domestic brands to expand its medical portfolio. The enterprise collaborates with healthcare professionals and hospitals to ensure its specialised chronic care medications are widely accessible to patients.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
